Skip to main content
. 2019 Nov 28;7(22):e14286. doi: 10.14814/phy2.14286

Figure 6.

Figure 6

Effects of single or combined treatment with ipragliflozin and pioglitazone on plasma levels of (a) leptin, (b) FGF‐21, and (c) adiponectin in type 2 diabetic mice with NASH. Ipragliflozin and/or pioglitazone was orally administered to diabetic mice with NASH for 4 weeks. Values indicate mean ± SEM for six animals per group. *p < .05 versus normal group, # p < .05 versus vehicle group, $ p < .05 versus pioglitazone (10 mg/kg) group